Kevin Sutherby will lead the company’s focus on delivering highest quality, end-to-end manufacturing solutions for the pharmaceutical, biotech and allied sectors
For the first time, neuroscientists from Charité – Universitätsmedizin Berlin and the Max Planck Institute for Biological Intelligence (currently in the process of being established) have revealed the precise connections between sensory neurons inside the retina and the superior colliculus, a structure in the midbrain. Neuropixels probes are a relatively recent development, representing the next […]
The highly selective RET inhibitor selpercatinib was well-tolerated and achieved durable objective responses across multiple tumour types in the Phase I/II LIBRETTO-001 trial, according to researchers from The University of Texas MD Anderson Cancer Center.
Avacta Group, a clinical stage oncology drug company and developer of diagnostics based on its innovative Affimer and pre|CISION platforms, has been granted Orphan Drug Designation (ODD) by the US FDA of the company’s lead pre|CISION drug candidate, AVA6000, for treatment of soft tissue sarcoma.
San Paolo Hospital in Savona, Italy, has upgraded its Corelab-related analytical equipment. In collaboration with Beckman Coulter, the San Paolo diagnostic laboratory has installed Beckman Coulter’s DxA 5000 Laboratory Automation System, an innovative, high-throughput automation system that rapidly increases test processing. This latest installation of Beckman Coulter’s DxA Automation System marks the 100th installation worldwide […]
Swedish medtech start-up Capitainer says its qDBS card has scored highly in a major new study published in Clinica Chimica Acta on the advantages of volumetric microsampling DBS devices in monitoring of patients with phenylketonuria (PKU). The study was necessary according to the authors, because although measurement of dried blood spot phenylalanine (Phe) is central […]
EpiEndo Pharmaceuticals, a clinical-stage biopharmaceutical company developing disease-modifying therapeutics for chronic respiratory disorders, has received regulatory and ethics approval to commence a Lipopolysaccharide (LPS) challenge clinical trial with lead molecule EP395. EP395 is an orally available macrolide or ‘Barriolide’ with reduced antimicrobial activity which aims to address the unmet medical need for a treatment for […]
Lifespin, based in Regensburg, Germany, with offices in Boston, Massachusetts, has launched a new commercial service that, for the first time, will provide the pharmaceutical and biobanking industry with access to its proprietary metabolic database, as well as its advanced interpretive software to assist in various phases of drug research, development, and manufacturing.
Absolute Antibody, an industry-leading provider of recombinant antibody products and services, is expanding its manufacturing facility in northeast England. The increased laboratory space includes a major investment in new automation for Next Generation Sequencing (NGS), expression and purification (HPLC) to enhance recombinant antibody production workflows. The additional space and equipment will enable Absolute Antibody to […]
BD (Becton, Dickinson and Company) and Accelerate Diagnostics, an innovator of rapid in-vitro diagnostics in microbiology, announced a worldwide commercial collaboration agreement where BD will offer Accelerate’s rapid testing solution for antibiotic resistance and susceptibility. The test offers results in hours, versus one to two days with some traditional laboratory methods.
Prins Hendrikstraat 1
5611HH Eindhoven
The Netherlands
info@clinlabint.com
PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.
